Pediatric Drugs and Vaccines: Global Strategic Business Report

Global Pediatric Drugs and Vaccines Market to Reach $156.7 Billion by 2030

The global market for Pediatric Drugs and Vaccines estimated at US$97.7 Billion in the year 2022, is projected to reach a revised size of US$156.7 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2022-2030. Conjugate, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$52 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Live Attenuated segment is readjusted to a revised 6.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $26.6 Billion, While China is Forecast to Grow at 10.1% CAGR

The Pediatric Drugs and Vaccines market in the U.S. is estimated at US$26.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$35.4 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$21.4 Billion by the year 2030.

Select Competitors (Total 76 Featured) -

• Abbott Laboratories
• Allergan Inc.
• Amgen Inc.
• AstraZeneca Plc
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Genentech Inc.
• GlaxoSmithKline Plc
• Janssen Biologics B.V
• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi
• Shionogi Inc.
• Shire Pharmaceuticals Group Plc

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year